Brad St Croix

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Cancer Therapeutics. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Biomed Valley Discoveries, Inc., Johns Hopkins University. Active years: 2008-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brad St Croix. Retrieved from https://idiyas.com/inventor/brad-st-croix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 67(Granted Patents)

Location History:

Cockeysville, MD (US) (2008)
Frederick, MD (US) (2008 - 2021)

Company Filing History:

13 out of 3,699

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

10 out of 43

Biomed Valley Discoveries, Inc.

patents

3 out of 3,806

Johns Hopkins University

Scott & White Healthcare (Swh)

patents

where one patent can have more than one assignee

Years Active: 2008-2021

Loading Chart...

Areas of Expertise:

Tumor-Associated Stroma

Combination Therapies

Anti-Metabolites

TEM8 Antibodies

Tumor Cells

Topoisomerase

Platinum Agents

Differential Gene Expression

Angiogenesis

Endothelial Cells

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11034757 - Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature (2021-06-15),

2. 11033621 - Combination therapies targeting tumor-associated stroma or tumor cells (2021-06-15),

3. 11033620 - Combination therapies targeting tumor-associated stroma or tumor cells and microtubules (2021-06-15),

4. 10799584 - Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agents (2020-10-13),

5. 10758614 - Combination therapies targeting tumor-associated stroma or tumor cells and topoisomerase (2020-09-01),

6. 10758613 - Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cells (2020-09-01),

7. 10758526 - Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathways (2020-09-01),

8. 10434174 - Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells (2019-10-08),

9. 10273299 - Antibodies to tumor endothelial marker 8 (2019-04-30),

10. 10196443 - TEM8 antibodies and their use in treatment and detection of tumors (2019-02-05),

11. 9765142 - TEM8 antibodies and their use in treatment and detection of tumors (2017-09-19),

12. 9309322 - Antibodies to tumor endothelial marker 8 (2016-04-12),

13. 9181340 - TEM8 antibodies, conjugates thereof, and their use (2015-11-10),

14. 8440411 - Differential gene expression in physiological and pathological angiogenesis (2013-05-14),

15. 7402660 - Endothelial cell expression patterns (2008-07-22),

Title: The Innovative Mind of Brad St Croix

Introduction: Brad St Croix, a talented inventor based in Frederick, MD, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Brad St Croix holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Brad St Croix has worked with leading tech companies to develop cutting-edge solutions that have revolutionized various industries. His commitment to pushing the boundaries of innovation has earned him recognition as a visionary in the field.

Collaborations: Throughout his career, Brad St Croix has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Brad St Croix's passion for innovation, coupled with his relentless drive to create a positive impact on society, sets him apart as a true pioneer in the world of technology. His continued dedication to pushing the boundaries of what is possible ensures that his legacy as an inventor will endure for years to come.

Profile summary based on public USPTO records.